Jejunum inflammation in obese and diabetic mice impairs enteric glucose detection and modifies nitric oxide release in the hypothalamus

Antioxidants and Redox Signaling

Volumn 14, Issue 3, 2011, Pages 415-423

  Duparc, Thibaut ^a,b   Naslain, Damien ^c   Colom, André ^a,b   Muccioli, Giulio G ^c   Massaly, Nicolas ^a,b   Delzenne, Nathalie M ^c   Valet, Philippe ^a,b   Cani, Patrice D ^c   Knauf, Claude ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; GLUCOSE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; INTERLEUKIN 1BETA; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MODEL; ENDOPLASMIC RETICULUM; ENTERITIS; HYPOTHALAMUS; JEJUNUM; MALE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL MARKERS; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE; HYPOTHALAMUS; INFLAMMATION; JEJUNUM; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

MUS;

EID: 78650880239     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2010.3330     Document Type: Article

References (36)

1. Cabou C, Campistron G, Marsollier N, Leloup C, Cruciani-Guglielmacci C, Penicaud L, Drucker DJ, Magnan C, and Burcelin R. Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity. Diabetes 57: 2577-2587, 2008.
2. Cabou C, Cani PD, Campistron G, Knauf C, Mathieu C, Sartori C, Amar J, Scherrer U, and Burcelin R. Central insulin regulates heart rate and arterial blood flow: an endothelial nitric oxide synthase-dependent mechanism altered during diabetes. Diabetes 56: 2872-2877, 2007.
3. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmee E, Cousin B, Sulpice T, Chamontin B, Ferrieres J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, and Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772, 2007.
4. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, and Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481, 2008.
5. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, Muccioli GG, and Delzenne NM. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103, 2009.
6. Chabrier PE, Demerle-Pallardy C, and Auguet M. Nitric oxide synthases: targets for therapeutic strategies in neurological diseases. Cell Mol Life Sci 55: 1029-1035, 1999.
7. Colombani AL, Carneiro L, Benani A, Galinier A, Jaillard T, Duparc T, Offer G, Lorsignol A, Magnan C, Casteilla L, Penicaud L, and Leloup C. Enhanced hypothalamic glucose sensing in obesity: alteration of redox signaling. Diabetes 58: 2189-2197, 2009.
8. Das UN. Obesity: Genes, brain, gut, and environment. Nutrition 26: 459-473, 2010.
9. Dietrich MO and Horvath TL. Feeding signals and brain circuitry. Eur J Neurosci 30: 1688-1696, 2009.
10. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buleon M, Cani PD, Attane C, Guigne C, Carpene C, Burcelin R, Castan-Laurell I, and Valet P. Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 8: 437-445, 2008.
11. Eizirik DL, Cardozo AK, and Cnop M. The role for endo-plasmic reticulum stress in diabetes mellitus. Endocr Rev 29: 42-61, 2008.
12. Feil R and Kleppisch T. NO=cGMP-dependent modulation of synaptic transmission. Handb Exp Pharmacol 84: 529-560, 2008.
13. Fioramonti X, Marsollier N, Song Z, Fakira KA, Patel RM, Brown S, Duparc T, Pica-Mendez A, Sanders NM, Knauf C, Valet P, McCrimmon RJ, Beuve A, Magnan C, and Routh VH. Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation. Diabetes 59: 519-528, 2010.
14. Guix FX, Uribesalgo I, Coma M, and Munoz FJ. The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol 76: 126-152, 2005.
15. Han MS, Chung KW, Cheon HG, Rhee SD, Yoon CH, Lee MK, Kim KW, and Lee MS. Imatinib mesylate reduces en-doplasmic reticulum stress and induces remission of diabetes in db=db mice. Diabetes 58: 329-336, 2009.
16. Hotamisligil GS. Inflammation and endoplasmic reticulum stress in obesity and diabetes. Int J Obes (Lond) 32 (suppl 7): S52-S54, 2008.
17. Knauf C, Cani PD, Ait-Belgnaoui A, Benani A, Dray C, Cabou C, Colom A, Uldry M, Rastrelli S, Sabatier E, Godet N, Waget A, Penicaud L, Valet P, and Burcelin R. Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure. Endocrinology 149: 4768-4777, 2008.
18. Knauf C, Cani PD, Kim DH, Iglesias MA, Chabo C, Waget A, Colom A, Rastrelli S, Delzenne NM, Drucker DJ, Seeley RJ, and Burcelin R. Role of central nervous system glucagon-like peptide-1 receptors in enteric glucose sensing. Diabetes 57: 2603-2612, 2008.
19. Knauf C, Cani PD, Perrin C, Iglesias MA, Maury JF, Bernard E, Benhamed F, Gremeaux T, Drucker DJ, Kahn CR, Girard J, Tanti JF, Delzenne NM, Postic C, and Burcelin R. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest 115: 3554-3563, 2005.
20. Knauf C, Prevot V, Stefano GB, Mortreux G, Beauvillain JC, and Croix D. Evidence for a spontaneous nitric oxide release from the rat median eminence: influence on gonadotropin-releasing hormone release. Endocrinology 142: 2343-2350, 2001.
21. Knauf C, Rieusset J, Foretz M, Cani PD, Uldry M, Hosokawa M, Martinez E, Bringart M, Waget A, Kersten S, Desvergne B, Gremlich S, Wahli W, Seydoux J, Delzenne NM, Thorens B, and Burcelin R. Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: role in liver and brain. Endocrinology 147: 4067-4078, 2006.
22. Li J, Hu X, Selvakumar P, Russell RR 3rd, Cushman SW, Holman GD, and Young LH. Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 trans-location in heart muscle. Am J Physiol Endocrinol Metab 287: E834-E841, 2004.
23. Martyn JA, Kaneki M, and Yasuhara S. Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. Anesthesiology 109: 137-148, 2008.
24. Moraes JC, Coope A, Morari J, Cintra DE, Roman EA, Pauli JR, Romanatto T, Carvalheira JB, Oliveira AL, Saad MJ, and Velloso LA. High-fat diet induces apoptosis of hypothalamic neurons. PLoS One 4: e5045, 2009.
25. Obici S. Minireview: molecular targets for obesity therapy in the brain. Endocrinology 150: 2512-2517, 2009.
26. Park SY, Shin HK, Lee JH, Kim CD, Lee WS, Rhim BY, and Hong KW. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db=db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription. J Pharmacol Exp Ther 329: 571-579, 2009.
27. Perrin C, Knauf C, and Burcelin R. Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis. Endocrinology 145: 4025-4033, 2004.
28. Pistell PJ, Morrison CD, Gupta S, Knight AG, Keller JN, Ingram DK, and Bruce-Keller AJ. Cognitive impairment following high fat diet consumption is associated with brain inflammation. J Neuroimmunol 219: 25-32.
29. Popeski N and Woodside B. Effect of nitric oxide synthase inhibition on fos expression in the hypothalamus of female rats following central oxytocin and systemic urethane administration. J Neuroendocrinol 13: 596-607, 2001.
30. Powell LA, Warpeha KM, Xu W, Walker B, and Trimble ER. High glucose decreases intracellular glutathione concentrations and upregulates inducible nitric oxide synthase gene expression in intestinal epithelial cells. J Mol Endocrinol 33: 797-803, 2004.
31. Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, and Li X. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab 9: 327-338, 2009.
32. Shankar R, Zhu J, Ladd B, Henry D, Shen H, and Baron A. Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action. J Clin Invest 102: 1403-1412, 1998.
33. Sohet FM, Neyrinck AM, Dewulf EM, Bindels LB, Portois L, Malaisse WJ, Carpentier YA, Cani PD, and Delzenne NM. Lipid peroxidation is not a prerequisite for the development of obesity and diabetes in high-fat-fed mice. Br J Nutr 102: 462-469, 2009.
34. Song D, Yao R, and Pang CC. Altered vasodilator role of nitric oxide synthase in the pancreas, heart and brain of rats with spontaneous type 2 diabetes. Eur J Pharmacol 591: 177-181, 2008.
35. Yamada T, Oka Y, and Katagiri H. Inter-organ metabolic communication involved in energy homeostasis: potential therapeutic targets for obesity and metabolic syndrome. Pharmacol Ther 117: 188-198, 2008.
36. Ye R, Jung DY, Jun JY, Li J, Luo S, Ko HJ, Kim JK, and Lee AS. Grp78 heterozygosity promotes adaptive unfolded protein response and attenuates diet-induced obesity and insulin resistance. Diabetes 59: 6-16.